Innoveren Scientific (IVRN) Stock Price

Innoveren Scientific Price

NYSE·CLOSED
0.00
​
Market closed

Revenue at Innoveren Scientific has contracted by 54.1% per year over the past 2 years to 453,500.00 USD. For Innoveren Scientific, the net margin of -2,271.1% is down versus -315.3% a few years ago.

Innoveren Scientific stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innoveren Scientific business model & stock analysis

H-Cyte, Inc. is a hybrid-biopharmaceutical company. The company is headquartered in Tampa, Florida. The company went IPO on 2014-12-19. The firm is focused on advancing new technologies in areas of unmet need across multiple indications for improving patient lives. The firm is also focused on investing in and fosters technologies that are supported by a scientific foundation.

Frequently asked questions about Innoveren Scientific

6 analysts currently rate the Innoveren Scientific stock: 0 recommend buying, 3 holding and 3 selling.

Converted at the current exchange rate, the Innoveren Scientific share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Innoveren Scientific.

The profit cannot currently be calculated for Innoveren Scientific.

The P/E ratio cannot be calculated for Innoveren Scientific at the moment.

The P/S cannot be calculated for Innoveren Scientific currently.

The Eulerpool Quality Score for Innoveren Scientific is 2/10.

The ISIN of Innoveren Scientific is US4041243076. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Innoveren Scientific is IVRN. The ticker symbol is used to trade Innoveren Scientific shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
17,442.31 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website hcyte.com
Currency
USD
Initial public offering
Dec 19, 2014
ISIN
US4041243076
Cusip
404124307
Market capitalization
213.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
270.99 %
Last updated Oct 16, 2026, 4:04 PM

Innoveren Scientific Peer Group

Innoveren Scientific FIGI

IVRN:US · BBG0081J2WN1HCYT:PQ · BBG0081J2X22IVRN:UV · BBG0081J2X40MDVXUSD:XH · BBG00K4XQ2F9MDVXUSD:XF · BBG00K4XQ2H7MDVXUSD:XE · BBG00K4XQ2K3MDVXUSD:XL · BBG00K4XQ2M1MDVXUSD:XG · BBG00K4XQ2N0MDVXUSD:XO · BBG00K4XQ2P8MDVXUSD:XA · BBG00K4XQ2V1MDVXUSD:XT · BBG00K4XQ2X9MDVXUSD:XW · BBG00K4XQ2Y8